9.10 Future Technology


Diabetic macular edema is currently an area of intense research and development. Several new agents for the treatment of DME are on the horizon. New technologies for retinal imaging are providing insights into the progression of DR and DME.

Quiz Module 9.10

1. Which of the following agents has anti-VEGF activity?

2. Which of the following appears to activate the Tie-2 pathway, a key control axis for retinal vascular stability?

3. Which anti-angiogenic small molecule has been evaluated in drop form?